Context: Indians are prone as a community to coronary artery disease (CAD) at a much younger age. CAD is affecting Indians 5-10 years earlier than other communities. Lipoprotein (a) (Lp (a)) is now recognized as an independent risk factor for CAD. It is a genetic risk factor. Aim: We evaluate the Lp (a) in young patients with myocardial infarction (MI). Settings and design: Study population consisted of 50 patients having MI and 50 control groups. Subjects and Methods: Fasting samples were collected from patients and were analyzed for Lp (a), lipid profi le, and blood sugar on fully automated analyzer. Statistical analysis used: Statistical analysis is carried out by using Student's t-test. Results: The difference in total cholesterol (P = 0.8192), high density lipoprotein-cholesterol (HDL-C) (P = 0.11), low density lipoprotein-cholesterol (LDL-C) (P = 0.8143), triglyceride (P = 0.1177) levels, and total cholesterol/HDLcholesterol ratio (P = 0.2129) were observed between the case and control groups in this study was not statistically signifi cant. The difference in the Lp (a) levels between the case and control groups was highly signifi cant (P-value = 0.0001).
INTRODUCTION
Developing countries, especially like India are on the verge of twin epidemics of communicable and noncommunicable diseases namely hypertension and coronary artery disease (CAD). The prevalence of CAD is high amongst Indians; 2.2 to fi ve times for myocardial infarction (MI) and 1.5 to three times for CAD mortality. MI also occurs at a younger age in Indians (50.2 versus 55.5 years in whites). [1] Age specifi c death rates (30-39) for MI in Indians were almost 10 times the rate observed for the white population. Autopsies also revealed more severe and extensive atherosclerosis and larger infarct size and increased frequency of triple vessel disease among Indians. [2] In CAD, fi rst reported from Singapore in 1959 reveal that people hailing from Indian subcontinent had a higher probability of dying due to CAD. The overall age standardized mortality ratio of CAD in Asian males compared to whites was 37.3% higher in age group of 20-29 years, compared to 36% higher at all ages in the UK. Asian Indians belonging to different geographical culture and religious groups have the same high mortality. Further, the prevalence of CAD is three-fold higher in south India in comparison to north India.
An important cluster of metabolic risk factors seems to be responsible for the occurrence of extensive and early CAD in Indians. These include the greater occurrence of glucose intolerance, hyperinsulinemia, hypertriglyceridemia, low high density lipoprotein-cholesterol (HDL-C) level, abnormal type of obesity, and novel risk factor like high serum lipoprotein (a) (Lp (a)).
Lp (a) constitutes an important inherited risk factor for atherosclerosis and is also regarded as biological marker for familial CAD. Lp (a) is homologous with the fi brin binding domain of plasminogen, a plasma protein that dissolves blood clots when activated. Lp (a) levels are also reduced by treatment with N-acetyl cysteine. Nicotinic acid and neomycin also decrease levels of Lp (a) and are used for therapeutic purpose. This study was designed to explore the role of Lp (a) levels in young patients with MI. Young patients in the study were defi ned as patients with age ≤40 years.
SUBJECTS AND METHODS
This case control study was carried out during the period of June 2008-January 2009 after prior approval from local ethical committee. Informed consent was taken from patients. Study population consisted of 50 patients having acute MI and diagnosed by clinical sign and symptoms, 12 lead electrocardiogram (ECG) and biochemical markers like creatinine kinase-MB (CK-MB) isoenzyme. Control group included 50 young individuals without ischemic heart disease.
Exclusion criteria include patient with uncontrolled diabetes mellitus, nephrotic syndrome, and treatment with any of lipid lowering agents.
Five milliliter of blood was collected in a plain bulb for estimation of Lp (a) and lipid profi le. Two milliliter of blood was collected in a fl uoride bulb for blood sugar estimation. Prior to sample collection, 10-12 h of fasting is required. Serum is preferred. Blood should be centrifuged within 30 min. Investigations like fasting blood sugar (FBS), postprandial 2 h blood sugar (PP 2 BS), blood urea, serum creatinine, serum CK-MB, lipid profi le, and serum Lp (a) were carried out in all patients and controls using commercially available kits on fully auto analyzer (Miura) machine. Serum Lp (a) was estimated by turbidimetric end point method. Comparison was carried out by using student's t-test. The differences were considered as signifi cant if P-value was <0.05.
RESULTS
Out of 50 patients with MI, 12 were females and rests of all were males (male to female ratio was 3.2). Thus, there was a male preponderance.
The difference in total cholesterol levels between the case and control group was not signifi cant (P-value = 0.8192). The difference in levels of HDL-C between the case and control groups was not statistically signifi cant (P-value = 0.11). The difference in low density lipoproteincholesterol (LDL-C) levels observed between the case and control groups in this study was not statistically signifi cant (P-value = 0.8143). The difference in the serum triglyceride levels between the case and control groups was not signifi cant (P-value = 0.1177). The difference in the total cholesterol/HDL-C ratio between the case and control groups was not signifi cant with the P-value of 0.2129. The Lp (a) levels in case patients with serum total cholesterol <200 mg% was statistically signifi cantly (P-value = 0.001) higher in compare to controls. The difference in the Lp (a) levels between the case and control groups was highly signifi cant (P-value = 0.0001) suggesting Lp (a) as an important predictor of coronary heart disease [ Tables 1-3] .
DISCUSSION
Lp (a) has many properties in common with LDL-C, but contains a unique protein, Apo (a), which is structurally different from other apolipoproteins. Apo (a) infl uences to major extent metabolic and physiochemical properties of Lp (a). [4] [5] [6] [7] There is an inverse relationship between Apo (a) size and Lp (a) levels. [8] [9] [10] Lp (a) promotes atherosclerosis by various mechanisms. [11] (a) The very low density lipoprotein (VLDL) receptors found on the macrophages present in atherosclerotic lesions can bind to and mediate the catabolism of Lp (a) by endocytosis, leading to its degradation within lysosomes. This would lead to a cellular accumulation of lipids within macrophages. Supporting this hypothesis is the observation that Lp (a) is ubiquitous in human coronary atheroma, co-localizes with plaque macrophages, and is detected in large amount in tissue from culprit lesions in patients with unstable compared to stable CAD. (b) Binding to endothelium and components of the extra cellular matrix, leading to endothelial dysfunction due to selective impairment of vasodilators capacity of receptor mediated endothelial stimuli. interference in normal pathways of thrombolysis, to predispose patients to acute thrombotic complications. [12] These all data shows that only Lp (a) is found signifi cantly (99.9%) higher in compare to controls in patients of MI, while serum total cholesterol, serum HDL-cholesterol, serum LDL-cholesterol, and serum triglyceride level does not have any signifi cant difference. It means Lp (a) has played role as independent risk factor for MI. The patient who did not have high levels of serum total cholesterol (<200 mg%), the higher levels of serum Lp (a) triggered the CAD. Thus, Lp (a) level is not dependent on serum total cholesterol level. This again means that Lp (a) can be an independent risk factor for MI. Sandkamp and Funke reported the same fi ndings. [13] Lp (a) is considered to be 10 times more atherogenic than LDL-C. [14] Relative risk of CAD is increased three-fold in males if Lp (a) levels are above 30 mg/dl. [15, 16] Adverse effects are enhanced by high LDL-C and low values of HDL-C.
